Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-12-20
2008-11-11
Gitomer, Ralph (Department: 1657)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S389200
Reexamination Certificate
active
07449309
ABSTRACT:
This invention provides a method of preventing or treating in a subject contact dermatitis which comprises administering to the subject an amount of a compound capable of inhibiting the stem cell factor signaling pathway effective to prevent or treat contact dermatitis so as to thereby prevent or treat contact dermatitis in the subject. This invention also provides a method of preventing or treating in a subject hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception.
REFERENCES:
patent: 5877396 (1999-03-01), Ravetch et al.
patent: 5911988 (1999-06-01), Brownell et al.
patent: 5997865 (1999-12-01), Bennett et al.
patent: 6576812 (2003-06-01), Longley
patent: 6977159 (2005-12-01), Longley
patent: 6989248 (2006-01-01), Longley
patent: 2003/0077282 (2003-04-01), Bigler et al.
Anderson, D.M., et al. (1990) “Molecular Cloning of Mast Cell Growth Factor, a Hematopoietin That Is Active in Both Membrane Bound and Soluble Forms,” Cell 63:235-243.
Bradl, M., et al., (1991) “Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice,” Proc. Nat. Acad. Sci. USA 88:6447-6451.
Costa, J.J., et al. (1996) “Recombinant Human Stem Cell Factor (Kit Ligand) Promotes Human Mast Cell and Melanocyte Hyperplasia and Functional Activation in Vivo,”, J. Exp. Med. 183:2681-2686.
Funasaka, Y., et al. (1992) “c-Kit-Kinase Induces a Cascade of Protein Tyrosine Phosphorylation in Normal Human Melanocytes in Response to Mast Cell Growth Factor and Stimulates Mitogen-Activated Protein Kinase But is Down-Regulated in Melanomas,” Mol. Biol. Cell 3:197-209.
Furitsu, T., et al. (1993) “Identification of Mutations in the Coding Sequence of the Protooncogenec-kitin a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation ofc-kitProduct,” J. Clin. Invest. 92:1736-1744.
Grichnik, J.M., et al., (1995) “Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients,” J. Am. Acad. Dermol. 33:577-583.
Hamann, K., et al., (1995) “Expression of stem cell factor in cutaneous mastocytosis,” Br. J. Dermatol. 133:203-208.
Harrist, T.J., et al. (1995) “Recombinant human stem cell factor(SCF) (c-kit ligand) promotes melanocyte hyperplasia and activation in vivo,” Lab. Invest. 72:48A.
Hirobe, T. (1984) “Histochemical Survey of the Distribution of the Epidermal Melanoblasts and Melanocytes in the Mouse During Fetal and Postnatal Periods,” Anat. Rec. 208:589-594.
Longley, J., et al., (1995) “The mast cell and mast cell disease,” J. Am. Acad. Dermatol. 32:545-561.
Longley, B.J., Jr., et al. (1993) “Altered Metabolism of Mast-Cell Growth Factor (c-kitLigand) in Cutaneous Mastocytosis,” N. Engl. J. Med. 328:1302-1307.
Longley, B.J., et al. (1996) “Somaticc-kitactivating mutation in urticaria pigmentosa and aggressive mastocytosis: establisHment of clonality in a human mast cell neoplasm,” Nat. Genet. 12:312-314.
Lu, H.S., et al. (1991) “Amino Acid Sequence and Post-translation Modification of Stem Cell Factor Isolated from Buffalo Rat Liver Cell-conditioned Medium,” J. Biol. Chem. 266:8102-8107.
Nishikawa, S., et al. (1991) “In uteromanipulation of coat color formation by a monoclonal anti-c-kitantibody: two distinct waves ofc-kit-dependency during melanocyte development,” EMBO J. 10:2111-2118.
Okura, M., et al. (1995) “Effects of Monoclonal Anti-c-Kit Antibody (ACK2) on Melanoctes in Newborn Mice,” J. Invest. Dermatol. 105:322-328.
Weiss, R.R., et al. (1995) “Human Dermal Endothelial Cells Express Membrane-Associated Mast Cell Growth Factor,” J. Invest. Dermatol. 104:101-106.
Tsai, M., et al. (1991) “The Ratc-kitLigand, Stem Cell Factor, Induces the Development of Connective Tissue-type and Mucosal Mast Cells in Vivo. Analysis by Anatomical Distribution, Histochemistry, and Protease Phenotype,” J. Exp. Med. 174:125-131.
Vassar, R., et al. (1989) “Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice,” Proc. Natl. Acad. Sci. USA 86:1563-1567.
Williams, D.E., et al. (1990) “Identification of a Ligand for thec-kitProto-Oncogene,” Cell 63:167-174.
Yarden, Y., et al. (1987) “Human proto-oncogenec-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand,” EMBO J. 6:3341-3351.
Yoshida, H., et al. (1996) “Distinct stages of melanocyte differentiation revealed by analysis of nonuniform pigmentation patterns,” Development 122:1207-1214.
Yoshida, H., et al. (1996) “Neural and Skin Cell-Specific Expression Pattern Conferred by Steel Factor Regulatory Sequence in Transgenic Mice,” Dev. Dyn. 207:222-232.
Zsebo, K.M., et al. (1990) “Stem Cell Factor Is Encoded at the S1 Locus of the Mouse and Is the Ligand for thec-kitTyrosine Kinase Receptor,” Cell 63:213-224.
Houdebine, L.M. (1994) “Production of pharmaceutical proteins from transgenic animals,” J. Biotechnol. 34:269-287.
Kappel, C.A., et al. (1992) “Regulating gene expression in transgenic animals,” Curr. Opin. Biotechnol. 3:548-553.
Sigmund, C.D. (2000) “Viewpoint: Are Studies in Genetically Altered Mice Out of Control?” Arterioscler. Thromb. Vasc. Biol. 20:1425-1429.
Wall, R.J. (1996) “Transgenic Livestock: Progress and Prospects for the Future,” Theriogenology 45:57-68.
Amendment submitted Jan. 16, 2001 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Amendment submitted Jan. 24, 2002 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Amendment submitted Jun. 24, 2002 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Communication submitted May 11, 2001 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Communication submitted Nov. 4, 2002 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Communication issued Apr. 23, 2002, including Notice to Comply in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Communication issued Oct. 2, 2002, including Notice to Comply in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Facsimile dated Dec. 13, 2002 in connection with U.S. Appl. No. 09/306,143, filed May 6, 2003.
Notice of Allowance issued Dec. 20, 2002, including Examiner's Amendment in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Office Action issued Apr. 11, 2001 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Office Action issued Aug. 2, 2001 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Office Action issued Jul. 13, 2000 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Office Action issued Mar. 31, 2005 in connection with U.S. Appl. No. 09/980,572, filed Sep. 23, 2002.
Preliminary Amendment And Information Disclosure Statement submitted Oct. 8, 1999 in connection with U.S. Appl. No. 09/306,143, filed May 6, 1999.
Ando A., et al. (1993) “Effects on chronic treatment with thec-kitligand, stem cell factor on immunoglobulin E-dependant anaphylacis, genetically mast cell-deficientSI/SIdmice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses,” J. Clin. Invest. 92:1639-49.
Askenase P., et al. (1983) “Defective elicitation of delayed-type hypersensitivty in W/Wv and SI/Sid mast cell deficient mice 1,” The Journal of Immunology 6:2687-2693.
Bischoff, S.C., et al. (1992) “c-kit ligand: a unique potentiator of mediator release by human lung mast cells,” J. Exp. Med. 175:237-44.
Coleman, J.W., et al. (1993) “Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4,” J. Immunol. 150:556-62.
Columbo M., “The human recombinant c-kit receptor ligand,” J. of Immunology 149(2)599-6
Cooper & Dunham LLP
Gitomer Ralph
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Methods for desensitizing a subject to an agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for desensitizing a subject to an agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for desensitizing a subject to an agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027300